Document is current
Any future updates will be listed below
-
Authors
Ikeda, Shota
Shinohara, Keisuke
Enzan, Nobuyuki
Matsushima, Shouji
Tohyama, Takeshi
Funakoshi, Kouta
Kishimoto, Junji
Itoh, Hiroshi
Komuro, Issei
Tsutsui, Hiroyuki
- License Information
-
More Information
Article History
Received: 18 August 2022
Revised: 26 December 2022
Accepted: 26 December 2022
First Online: 27 January 2023
Compliance with ethical standards
:
: KS reports grants from Daiichi Sankyo, Nippon Boehringer Ingelheim, and Otsuka Medical Devices. HI reports personal fees from SBI Pharmaceuticals, Wakunaga Pharmaceutical, NIPRO, Meiji, Taisho Pharmaceutical, Ono Pharmaceutical, Kowa, Takeda Pharmaceutical, Daiichi Sankyo, and Novartis Pharma. IK reports grants and/or personal fees from Idorsia Pharmaceuticals Japan, Daiichi Sankyo, Takeda Pharmaceutical, Mitsubishi Tanabe Pharma, Teijin Pharma, AstraZeneca, Kowa, MSD, Otsuka Pharmaceutical, Ono Pharmaceutical, Nippon Boehringer Ingelheim, Novartis Pharma, and Bayer Yakuhin. HT reports grants and/or personal fees from Daiichi Sankyo, Novartis Pharma, Otsuka Pharmaceutical, Pfizer Japan, Mitsubishi Tanabe Pharma, Teijin Pharma, Nippon Boehringer Ingelheim, AstraZeneca, Ono Pharmaceutical, Kowa, IQVIA Service Japan, MEDINET, Medical Innovation Kyushu, Bayer Yakuhin, Johnson & Johnson, NEC, Nippon Rinsho and Japanese Heart Failure Society. Other authors report no conflicts of interest.
